American Oncology Network, LLC (AON) is pleased to announce that The Center for Cancer and Blood Disorders (CCBD), a leading community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON.
Fort Myers, Fla., May 4, 2020—American Oncology Network, LLC (AON) is pleased to announce that The Center for Cancer and Blood Disorders (CCBD), a leading community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON, effective May 1, 2020. The Center for Cancer and Blood Disorders team includes three medical oncologists providing the highest quality of care, with state-of-the-art technology, and the latest advances in clinical research and therapies. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. The partnership with AON will help expand patient services such as home delivery of oral oncolytic medications, patient education, and 24/7 pharmacy assistance.
AON CEO Brad Prechtl, MBA stated, “We are excited for Drs. Boccia, Priego and Goldstein and the entire Center for Cancer and Blood Disorders team to join our growing network of community oncologists helping to bring the very best in cancer care and treatment to patients, close to where they live.”
“The Center for Cancer and Blood Disorders will remain focused on integrating the best medicine in an environment that helps patients overcome obstacles such as easier access to medications and financial counseling,” said AON Board Member & Chairman Dr. Stephen Orman.
Read the full press release here.
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More